# Eradication of Malignant Carcinoma in the Breast Tissue

> **NCT02286778** · PHASE2,PHASE3 · COMPLETED · sponsor: **Optimal Health Research** · enrollment: 60 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** Acetogenins
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT02286778
- **Lead sponsor:** Optimal Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2017-01
- **Final completion:** 2017-08-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02286778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02286778, "Eradication of Malignant Carcinoma in the Breast Tissue". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02286778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*